Related Experiment Video
Updated: Dec 23, 2025
06:34
A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
Published on: June 4, 2017
10.3K
Evaluation of a Mobile Phone App for Patients With Pollen-Related Allergic Rhinitis: Prospective Longitudinal Field
Manuela Glattacker1, Martin Boeker2, Robin Anger1
1Section of Health Care Research and Rehabilitation Research, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
JMIR Mhealth and Uhealth
|April 18, 2020
Summary
The Husteblume app shows promise for self-managing allergic rhinitis, with users reporting subjective improvements in allergy management and information, though objective health outcomes did not significantly change. Further research is needed to confirm its effectiveness.
Area of Science:
- Digital Health
- Allergy Management
- Mobile Health Applications
Background:
- Mobile health (mHealth) apps offer potential for chronic condition self-management, including allergic diseases.
- The mHealth market is vast and lacks scientific validation, making user navigation difficult.
- No mHealth app for pollen-related allergic rhinitis has been scientifically evaluated.
Purpose of the Study:
- To evaluate the Husteblume mobile health app for self-management of pollen-related allergic rhinitis.
- Assess usability, quality of life, health literacy, and self-efficacy among app users.
Main Methods:
- Two online surveys were conducted with registered Husteblume app users (N=661 at baseline, N=143 at follow-up).
- Data collection occurred before and after the 2017 pollen season for cross-sectional and longitudinal analysis.
- Evaluated usability, quality of life, health literacy, and self-efficacy in a real-world setting.
Main Results:
- Follow-up users rated app usability as good to very good.
- No significant changes were observed in objective quality of life, health literacy, or self-efficacy.
- A significant proportion of follow-up users reported subjective benefits: better allergy information (55.9%), improved quality of life (27.3%), better coping (33.6%), and enhanced physician consultation preparation (28.0%).
- No adverse effects were reported by 90.9% of follow-up users.
Conclusions:
- The Husteblume app evaluation shows encouraging results for long-term users, particularly regarding subjective improvements.
- Methodological limitations exist, warranting cautious interpretation of the findings.
- Further studies are necessary to rigorously evaluate the app's clinical effectiveness in managing allergic rhinitis.
